Skip to search formSkip to main contentSkip to account menu

interferon beta-1b 0.3 MG Injection [Betaseron]

Known as: INTERFERON BETA-1B 0.3MG/VIL (BETASERON), INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON), Betaseron 0.3 MG Injection 
National Institutes of Health

Related topics

Related topics

10 relations
Albumin Human, USPBetaseronDrug AllergyInjection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Ein Paradigmenwechsel und die Zukunft
In der wechselvollen und sehr dynamischen Entwicklung der Therapien der Multiplen Sklerose (MS) stellt Interferon beta-1b… 
2012
2012
Disease-modifying drugs for multiple sclerosis and JC virus expression
Natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis (MS) occurred in two individuals also… 
2012
2012
Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency… 
2011
2011
Dianas farmacológicas en la esclerosis múltiple
La esclerosis multiple es la enfermedad inflamatoria, desmielinizante y neurodegenerativa cronica mas frecuente en jovenes… 
Review
2009
Review
2009
Dose response to interferon therapy in multiple sclerosis: an evaluation of the evidence
ABSTRACT Background: Interferon beta (IFNβ) is a disease-modifying therapy for multiple sclerosis (MS). Although clinical… 
2009
2009
Effect of anti-IFNβ antibodies on MRI lesions of MS patients in the BECOME study
Background: Interferon beta (IFNβ) administered subcutaneously is immunogenic in some patients with multiple sclerosis (MS) and… 
Review
2009
Review
2009
Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit
Background The therapeutic goal for multiple sclerosis (MS) is to achieve a better long-term outcome. However, since available… 
2004
2004
The safety, tolerability and pharmacodynamic responses of interferon BETA‐1A (Rebif®) versus interferon BETA‐1B (Betaseron®) in healthy male volunteers
1993
1993
Beyond Betaseron®: current directions for MS research
The approval of Betaseron® has drawn attention to the potential of immune modulation as a means of treating multiple sclerosis… 
1986
1986
The isolation of human beta-interferon receptor by wheat germ lectin affinity and immunosorbent column chromatographies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)